0.00
Mainz Biomed N V 주식(MYNZ)의 최신 뉴스
QUCY Stock Price, News & Analysis - Stock Titan
Mainz Biomed Sells Next Gen Colorectal Cancer IP to Focus on Pancreatic Cancer and Post-Quantum Cybersecurity 7 - Minichart
Mainz Biomed NVenters asset purchase agreement on April 9, 2026 for next gen IP saleSEC filing - marketscreener.com
Mainz Biomed (NASDAQ: MYNZ) sells cancer IP and lifts equity above Nasdaq minimum - Stock Titan
An undisclosed buyer entered into a definitive agreement to acquire Next Gen IP of Mainz Biomed N.V. for ?1.2 million. - marketscreener.com
QUCY|Mainz Biomed N V Ord Shs|Price:0.546|Chg%:-0.06 - TradingKey
TradingKey - TradingKey
QUCY|Mainz Biomed N V Ord Shs|Price:0.503|Chg%:-0.04 - TradingKey
QUCY|Mainz Biomed N V Ord Shs|Price:0.487|Chg%:-0.02 - TradingKey
Fundamentals Check: Is Mainz Biomed NV a defensive stockQuarterly Earnings Report & Proven Capital Preservation Methods - baoquankhu1.vn
Purchase/sale of business (net) of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Aug Retail: Whats the beta of Mainz Biomed NV stockTrade Performance Summary & Growth Focused Entry Reports - baoquankhu1.vn
Why Is Mainz Biomed N.V. (QUCY) Stock Up Today? - Meyka
QUCY: Mainz Biomed NVComparative Chart - Zacks Investment Research
Mainz Biomed 10-K: Revenue $0.537M, EPS $(2.70) - TradingView
Mainz Biomed N.V. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Mainz Biomed (NASDAQ: QUCY) takes $16.2M loss and plans major Lazar-led recapitalization - Stock Titan
Mainz Biomed NV expected to post a loss of $2.80 a shareEarnings Preview - TradingView
Update Recap: Whats the beta of Mainz Biomed NV stock2026 Volume Leaders & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Smart Money: Whats the beta of Mainz Biomed NV stock2026 AllTime Highs & Breakout Confirmation Trade Signals - baoquankhu1.vn
Mainz Biomed N.V. Receives Nasdaq Notice for Non-Compliance with Minimum Bid Price Rule - Minichart
Mainz Biomed Receives Nasdaq Notice on Bid Price - TipRanks
Mainz Biomed NV (QUCY) Gross Margin (TTM) - zacks.com
Lazar financing could give Mainz Biomed (NASDAQ: MYNZ) 95%+ stake and new direction - Stock Titan
Mainz Biomed Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Nasdaq warns Mainz Biomed (MYNZ) over sub-$1.00 bid and possible delisting risk - Stock Titan
Growth Recap: How much upside does Mainz Biomed NV have2026 Major Catalysts & Weekly Momentum Picks - baoquankhu1.vn
Mainz Biomed N.V. (QUCY) Fundamental Analysis - Meyka
Why Is Mainz Biomed N.V. (QUCY) Stock Down Today? - Meyka
Top Mainz Biomed (QUCY) Competitors 2026 - MarketBeat
Block Trades: Can Mainz Biomed NV be recession proofMarket Trend Review & Short-Term High Return Strategies - baoquankhu1.vn
Trend Review: How does Mainz Biomed NV compare to its peersGold Moves & Low Risk Growth Stock Ideas - baoquankhu1.vn
Mainz Biomed changes ticker symbol to QUCY - MSN
QUCY Technical Analysis & Stock Price Forecast - Intellectia AI
QUCY Technical Analysis | Trend, Signals & Chart Patterns | MAINZ BIOMED NV (NASDAQ:QUCY) - chartmill.com
Mainz Biomed (QUCY) Stock Chart and Price History 2026 - MarketBeat
Mainz Biomed (QUCY) Stock Forecast and Price Target 2026 - MarketBeat
Total cash dividends paid of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Published on: 2026-03-19 07:11:22 - baoquankhu1.vn
What is the current Price Target and Forecast for Mainz Biomed NV (QUCY) - Zacks Investment Research
Mainz Biomed N.V. Earnings and Revenue – NASDAQ:QUCY - TradingView
Pullback Watch: Whats the beta of Mainz Biomed NV stock2026 Year in Review & Weekly Watchlist of Top Performers - baoquankhu1.vn
Mainz Biomed (QUCY) Stock Trends and Sentiment 2026 - MarketBeat
Mainz Biomed receives $3M tranche from shareholder Lazar By Investing.com - Investing.com South Africa
All News for QUCY : Mainz Biomed NV - Zacks Investment Research
Mainz Biomed receives $3M tranche from shareholder Lazar - Investing.com
Quantum Cyber (NASDAQ: QUCY) backed by $6M pre-funded Lazar funding - Stock Titan
자본화:
|
볼륨(24시간):